Abstract. Photoacoustic imaging is an emerging hybrid imaging modality that can provide multicontrast, multiscale imaging of biological features ranging from organelles to organs. The three major embodiments of photoacoustic imaging are microscopy, endoscopy, and computed tomography. Photoacoustic tomography (PAT) or photoacoustic computed tomography allows deep-tissue imaging, and hence it is more suitable for whole body preclinical/clinical imaging applications. Due to fast-growing laser technology and ultrasound detector technology, PAT is evolving rapidly, leading to a quicker translation into clinical trials. We review the recent developments of PAT systems and their applications in preclinical and clinical practices.
Introduction
Medical imaging is continuously advancing along with newer technologies. The advances in medical imaging tools [x-ray computed tomography (x-ray CT), ultrasound (US), magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography etc.] have led to better diagnosis and patient care. [1] [2] [3] [4] In the last decade, a new imaging technology called photoacoustic imaging (PAI) has evolved and is moving rapidly from the laboratory to preclinical and clinical phases. [5] [6] [7] PAI is a three-dimensional (3-D) hybrid imaging modality that combines the advantage of optical and acoustic imaging. In PAI, a nanosecond laser illuminates the target sample (tissue/body parts). Due to absorption of incident light by the tissue chromophores (such as melanin, red blood cells, and water), there is a local temperature rise, which in turn produces pressure waves emitted in the form of acoustics waves [also known as photoacoustic (PA) waves]. By acquiring the generated PA waves at the tissue surface, images can be formed, revealing the internal structures and function. PAI provides anatomical, functional, metabolic, molecular, and genetic contrasts of vasculature, hemodynamics, oxygen metabolism, biomarkers, and gene expression. 7, 8 These unique advantages made PAI a potential tool for many applications in vascular biology, oncology, neurology, ophthalmology, dermatology, gastroenterology, and cardiology. 7 The merits of PAI compared with pure optical and pure ultrasonic imaging modalities are: (i) it has high intrinsic optical absorption contrast, hence no labeling is required, (ii) it can provide better penetration depth (0.1 to 12 cm) 9 compared to optical methods, such as optical microscopy, fluorescence microscopy, 10 Raman microscopy, 11, 12 multiphoton microscopy, 13 optical coherence tomography, 14, 15 and diffuse optical tomography, 16 (iii) unlike US imaging, PAI is free from speckle artifacts, (iv) it is compact, faster, and less expensive compared with MRI, PET, and x-ray CT, (vi) it can provide both structural and functional information using multiwavelengths, (vii) it directly images optical absorption with 100% relative sensitivity and the sensitivity is two orders of magnitude greater than those of confocal microscopy and optical coherence tomography, 7 and (viii) it can provide multiscale multicontrast images of biological structures, ranging from organelles to organs.
Several comprehensive reviews on PAI can be found in the literature. 6, 7, [17] [18] [19] [20] [21] [22] Three types of PAI systems have been reported: (i) photoacoustic microscopy (PAM), [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] (ii) photoacoustic endoscopy (PAE), [40] [41] [42] [43] [44] [45] (iii) photoacoustic tomography (PAT) or photoacoustic computed tomography (PACT). [46] [47] [48] [49] [50] [51] [52] [53] [54] In PAM, both the laser excitation and acoustic detection are focused (tightly or loosely depending on the configuration), and the dual foci are configured confocally to enhance measurement sensitivity. Depending on whether the acoustic focus or optical focus is finer, PAM is categorized into acoustic-resolution PAM 32, [37] [38] [39] or optical-resolution PAM. 24, 30, 34 Subwavelength PAM was also demonstrated to achieve nanometric resolution in PAM systems. [55] [56] [57] [58] Like PAM, PAE is used to image internal organs, such as, the esophagus and colon. Unlike optical endoscopy, PAE can provide much deeper imaging. A 7-mm deep PAE imaging was demonstrated in the dorsal region of a rat colon ex vivo. 44 Both PAM and PAE are still limited to shallower imaging depth (with higher spatial resolution). For deep tissue, imaging PAT/PACT will be more suitable and hence holds a better chance to find a clinical application. This review will focus on the progress of the PAT system in recent years for translating into preclinical and clinical applications.
In PAT, typically an expanded nanosecond laser beam illuminates the tissue surface homogeneously. PA waves are acquired around the tissue boundary using a wideband ultrasound transducer (UST). Generally, circular scanning geometry in orthogonal excitation mode is preferred for deep-tissue imaging. The acquired PA signals are used to reconstruct the initial pressure 2 Single-Element Transducer-Based Preclinical PAT Systems
SET-Based PAT System Using Nd:YAG Laser
It is a widely used configuration for laboratory and preclinical studies. Here the expanded laser beam irradiates the test sample, and the SET circularly rotates around the sample to collect PA signals at different angles. SETs have been widely used in PAT owing to low-cost, wide availability, and high sensitivity. In SET-based systems, A-lines PA signal can be acquired in two different ways: (i) stop-and-go scan: 79, 80 A stepper motor moves the UST to a predefined position, collects multiple PA signals for averaging, saves the A-lines, and moves the UST to the next position, (ii) continuous scan: 81 the stepper motor rotates the UST continuously at predefined speed, collects PA signals while the UST is moving, and saves the A-lines once the rotation is complete. Signal averaging can also be done later if needed. Continuous scan is faster than the stop-and-go scan. However, care should be taken while choosing the scan speed in continuous scanning to minimize the blur due to the UST motion or due to averaging. The blur should be negligible compared to the imaging resolution or object size to be imaged. Because the SET has a large active area (to increase sensitivity), it impacts the tangential resolution, especially when the sample is far from the scanning center (or closer to the UST surface). To increase the signal acceptance angle (and improve the tangential resolution), a negative lens can be added to the transducer surface. 82, 83 More recently, a modified delay-and-sum reconstruction algorithm was proposed to improve the tangential resolution without using any negative lens or virtual US detector. density on the surface of the sample was maintained at ∼11 mJ∕cm 2 (<ANSI safety limit 20 mJ∕cm 2 ) 87 to provide an effective penetration depth of no less than 9 mm. This is deep enough to cover the crown of a tooth, where the early lesions often happen. The PA signals were collected by a UST [central frequency (f c ) ∼4.39 MHz, bandwidth (BW) ∼100.2% at −6 dB, V310/Panametrics] while scanning around the tooth. The UST was moved around the tooth with 120 steps in a circle for one complete scan. The signals were amplified (SA-230F5, NF), and recorded by a data-acquisition (DAQ) card (PCI-5105, National Instruments) with sampling frequency of 60 MHz. The signals were averaged 40 times to reduce noise at each UST position. A linear stage was employed to control the position of the scanning plane of the tooth in the vertical direction.
The mode-1 and mode-2 images of a healthy tooth are shown in Figs. 1(b) and 1(c). The mode-1 contrast comes from the diversity of optical absorption; the mode-2 contrast is related to the microstructure and mechanical properties of the tooth. The tooth crown consists of two layers: (i) enamel is the white, protective external surface of the anatomic crown and has weaker optical absorption and (ii) dentin is the yellowish tissue underlying the enamel making up the major bulk of the inner portion, and has stronger optical absorption than the enamel. The mode-1 image clearly shows the enamel (outer dark region) and dentin (inner bright region). The mode-2 image of the same cross-section shows two-layer concentric structure with clear boundary. Figures 1(d) and 1(e) show the images of a lesion. Here, the mode-1 contrast clearly shows the shape, size, and macrostructure of the tooth cross-section, but, it fails to show significant contrast on the dental lesions. However, the mode-2 contrast clearly shows the lesions in the tooth.
Multitransducer-Based PAT with Nd:YAG Laser
In this system, an electrical slip ring was used to rotate multiple SETs around the sample. Figures 2(a) and 2(b) show the schematic and photograph of the system. 88 A slip ring is a device for transmitting electrical power through rotators, which can avoid the cable intertwist problem of the rotating UST. This is the first time a slip ring was used in a PAI setup. A Ti:Sapphire laser (λ ∼ 808 nm, PW ∼ 12 nm, RR ¼ 10 Hz, LT-2211A, LOTIS TII, Minsk, Belarus) was used as an excitation source. The diverging ring-shaped beam from the conical lens was reflected by an acoustically penetrable optical reflector (APOR) to irradiate the sample surface at a horizontal plane. The laser fluence at the surface was ∼15 mJ∕cm 2 (less than 20 mJ∕cm 2 ANSI safety limit). The signals of each transducer were preamplified 28 dB (ZFL500LN, Mini-Circuit, New York) before passing through the slip ring, and then amplified another 32 dB (5072PR, Olympus NDT, Massachusetts) before being digitized. The amplified signals were recorded by a DAQ card with a sampling rate of 100 MHz (CSE4327, DynamicSignals, LLC, Illinois). For each cross-sectional scanning, 1800 signals were acquired and then reconstructed by the simple delay-and-sum algorithm. Two identical cylindrically focused transducers with a central frequency of 5 MHz (V307, Olympus NDT, Massachusetts) were used to collect the PA signals.
The system was tested on in vivo animal study on a ∼20-g BALB/c male nude mouse. During imaging, the mouse was anesthetized by an isoflurane machine (0.8% to 1.0% vaporized isoflurane with an oxygen airflow rate of 1.0 L∕ min). Crosssectional images showing the spinal cord, kidneys, liver, and one major vessel are shown in Figs. 
2(c)-2(h). Figure 2(i)
shows the area of the animal where PA cross-sectional images were recorded. The signal-to-noise ratio (SNR) of in vivo images was ∼25 dB. The total imaging time was 9 min. These results promise that the system could provide in vivo animal whole-body imaging.
Although Nd:YAG/ OPO or dye-based lasers could provide high energy pulses for deep-tissue PAT imaging, these are expensive, bulky (even require optical table to house them), and are not suitable for high-speed imaging with SET due to the low laser pulse RR. Typically, it takes several minutes to obtain one cross-sectional image. Portable OPO lasers are commercially available but are even more expensive.
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Alternatively, PLD and LED can be promising light excitation sources which could make PAT a low-cost, high-speed, and portable system.
SET-Based PAT with Pulsed Laser Diode
The PLD-PAT system is shown in Figs. 3(a) and 3(b) . 47, 59 Here, the laser was integrated inside the scanner. The PLD (λ ∼ 803 nm, PW ∼ 136 ns, RR ¼ 7 kHz, PE ∼ 1.4 mJ, Quantel, France) was the excitation source. The PLD was controlled by the laser driver unit (LDU) which consists of a temperature controller (LaridTech, MTTC1410), a 12-V power supply (Voltcraft, PPS-11810), a variable power supply (to change the laser output power), and a function generator (to control the laser RR). The PE and RR can be controlled independently with variable power supply (BASETech, , and function generator (FG250D, Funktionsgenerator), respectively. The function generator provides a transistor-transistor logic) signal to synchronize the DAQ with the laser excitation. A flat UST (V323/SU, f c ∼ 2.25 MHz, BW ∼ 70%, Olympus NDT) was driven by a step motor (M) (Lin Engineering, Silverpak 23C) to scan circularly around the sample. The UST detected signals were subsequently amplified, and band pass filtered by the US signal receiver (R/A/F) unit (Olympus-NDT, 5072PR), and then digitized and recorded by the PC with DAQ card (GaGe, compuscope 4227). The DAQ was done at 25 Ms∕s.
High-speed PAT images obtained on a horse hair phantom are shown in Figs. 3(c) and 3(d). 59 These images were obtained in 5 s, and 3 s scan time using 2.25-MHz UST. The hair has a side-length of ∼8 mm and a diameter of ∼150 μm. Deep-tissue imaging experiments were carried out on a chicken breast tissue in which two low-density polyethylene (LDPE) tubes (∼12-mm long and ∼0.59-mm inner diameter) were filled with mouse blood and indocyanine green (ICG). The radiation density on the tissue surface was ∼0.3 mJ∕cm 2 . PAT images were acquired using 2.25 MHz for 5 s, 3 s scan time at 1 cm, and 2 cm depth, respectively, as shown in Figs. 3(e)-3(h) . The SNR values of blood, ICG measured at 1 cm are ∼25, ∼32 and that measured at 2 cm are ∼8, ∼14. The performance of PLD-PAT was compared against the Nd:YAG/OPO-PAT system and the results were summarized in Table 1 . 47 From Table 1 , it is clear that the PLD-PAT can provide 2-cm imaging depth and acceptable images in 3 s. The low PE was slightly compensated by the higher RR of PLD. Since the PLD was integrated inside the scanner, it makes the overall system compact and portable.
The PLD-PAT system was demonstrated for in vivo small animal brain imaging. 92 Figures 3(i)-3(k) show the in vivo brain images of a healthy rat. The superior sagittal sinus (SS) and transverse sinuses (TS) of the rat brain are clearly visible. The plot in Fig. 3(l) shows the image SNR as a function of scan time. These results promise that the PLD-PAT system could provide high-speed in vivo imaging for preclinical applications.
SET-Based PAT with Light-Emitting Diode
The PLDs suitable for PAT are typically available at wavelengths greater than 750 nm. The LEDs are readily available at wavelengths below 650 nm where hemoglobin absorption is significantly higher, offering high contrast for superficial vascular imaging applications. The use of LEDs for PA imaging has been explored. Figure 4(a) shows the schematic of the LED-PAT system. 62 A high power SST-90 LED (λ ∼ 623 nm, PW ∼ 200 ns, RR ∼ 500 Hz, PE ∼ 9 μJ) from Luminus was used as an excitation source. It was driven by a driver (PCO-7120, Directed Energy, Inc.), which provided a peak current of 50 A. The LED was operated at low duty cycle 0.01% for its safety. Figures 4(b) and 4(c) show the PA images of the phantom. The phantom was comprised of three 1.4-mm-diameter poly methyl methacrylate tubes filled with human blood (35% hematocrit) immersed in 1% intralipid (μ s ¼ 1 mm −1 ). The three tubes were fixed in a mount that was rotated by 360 deg in steps of 0.9 deg using a stepper motor. The phantom was illuminated by LED with ∼11.5 μJ∕cm 2 energy density at 623 nm. The signals were collected by a cylindrically focused UST (f c ∼ 3.5 MHz, V383/Panametric). The signals were amplified using a low noise voltage amplifier (60 dB, Analog Modules Inc.), averaged 5000 times and saved in a computer. This study has explored the use of low-cost visible LEDs (<50) as a PA excitation source. At 500-Hz RR, LED-PAT could image blood tubes immersed to a depth of 15 mm in Intralipid. This suggests that in vivo imaging of the vasculature to depths of a few mm should be possible with LED-PAT. A four-wavelength LED was also demonstrated for spectroscopic applications. This study presents a step toward the development of compact, inexpensive visible, and near-infrared multiwavelength excitation sources for PAT. 62 In spite of single-element large detector area transducers providing the low-cost PAT imaging system with high sensitivity, it is challenging to achieve real-time imaging. The time required to collect multiple A-lines data for a cross-sectional PAT image reconstruction is too slow, since a motor driven mechanism is required to move the detector around the sample. The fastest imaging speed demonstrated so far using a single-element US transducer is 3 s per cross-sectional imaging. 47 Therefore, for faster real-time imaging a US array transducer is required. In Sec. 3, we will discuss array transducer-based PAT imaging systems.
Ultrasound Array Transducer-Based Preclinical PAT Systems
In traditional pulse echo US imaging, array transducers (linear array, phased array, and curved array) have replaced singleelement transducers decades back. It helped US imaging devices to become real-time, portable, and handheld. Similarly, the PA community has also adopted array transducers (linear, semicircular, circular, and spherical array) to develop highspeed/real-time PA imaging. 48, 63, [64] [65] [66] [93] [94] [95] In the following sections, we will discuss the recent progress in PAT systems with array-based USTs that could translate the PAT from bench to bedside. A laser optoacoustic imaging system (LOIS) based on semicylindrical array of transducers was reported for breast cancer detection. 64 The system was designed to image a single breast slice in craniocaudal or mediolateral projection with an arcshaped array of 64 ultrawide-band acoustic transducers. The LOIS system was clinically tested on 27 patients, and the system could provide high contrast PAIs of breast tumors, taking advantage of the blood optical absorption in the angiogenesis-related microvasculature. A functional photoacoustic tomography (fPAT) system was developed for functional imaging of breast lesions with high resolution. 96, 97 The system consists of a tunable pulsed Ti:sapphire laser pumped with a Q-switched Nd:YAG laser (Symphotic Tii, Camarillo, California) and a ring-shaped array of 64 acoustic transducers having maximum frequency response up to 2 MHz. Functional images of breast tissue including absolute total hemoglobin concentration (HbT) and oxygen saturation (StO 2 %) were obtained by fPAT. Hb T and StO 2 % maps from pathology-confirmed cancer cases showed clear detection of tumors.
Circular Planar
A circular planar array-based PAT, named as Twente photoacoustic mammoscope, was reported for breast imaging. 98 The schematic of the system is shown in Fig. 5(a) . A Q-switched Nd:YAG laser (λ ∼ 1064 nm, PW ∼ 10 ns, RR ∼ 10 Hz, PE ∼ 350 mJ) from Continuum Surelite, California, was used for PA excitation. The beam was maintained at a fixed position on the breast surface, with a beam area of ∼35 cm 2 and an energy density of ∼10 mJ∕cm 2 (less than 100 mJ∕cm 2 ANSI limit) on the skin. 101, 102 The US array consists of 588 elements (f c ∼ 1 MHz, BW ∼ 130%) in a circular layout with diameter of 85 mm. The elements are grouped into 10 sectors; each sector is ∼60 elements serviced by an application-specific IC (ASIC), which buffers and amplifies the signals. Each ASIC has a single output that leads to a 10 input summing amplifier. In the upgraded mammoscope, the outputs of the 10 ASICs are made to bypass the buffers, amplifiers, and summing amplifier. An independent interface unit was developed with 10 channel buffer-amplification based on the AD797AR (Analog Devices) ultralow noise op-amp. The 10 outputs are acquired at a time using two eight-channel digitizers (National Instruments PXI 5105, 60 MS∕s, 12-bit) controlled by a Labview program. With averages over 10 signals per acquisition, an imaging time of 10 min was required for the complete detector area covering an field-of-view of 90 × 85 mm 2 on the breast. The results show that there is good correspondence in lesion colocalization, appearance, and shape in the PAT and MRI images. The study proved that PA imaging has potential in visualization of breast cancer. For the first time, mass-like, nonmass, and ring appearances were observed in PA image intensities. However, the system needs to be tested on a large number of patients before going for clinical practice.
Semispherical Array-Based PAT Systems
A PAT system was reported for 3-D visualization of vasculature in human breast. 100, 103 The device consists of an array of 128 elements with 5-MHz central frequency and 3 mm diameter laid out in a spiral pattern on a semispherical surface with a 100-mm radius of curvature. The system could provide maximum depth of 40 mm, and its spatial resolution ∼250 μm was uniform over a 64 × 64 × 50 mm field of view. A PAT system with advanced semispherical array was demonstrated for volumetric imaging. 104 The imaging system is based on simultaneous acquisition of PA signals by means of a custom-made matrix ultrasonic array (f c ∼ 3.9 MHz, BW ∼ 4 MHz, Imasonic SaS, Voray, France) consisting of 256 elements densely distributed on a spherical surface [ Fig. 6(a) ]. The radius of the array is 40 mm and its outer diameter is 64 mm. Acoustic coupling of the PA signals to the detectors was done by means of a transparent impermeable membrane containing water. Acoustic gel is used to guarantee coupling between the membrane and surface of the imaged region. The detection array further includes a central cylindrical cavity with a diameter of 8 mm through which optical illumination was delivered. The output of an OPO laser (680 to 900 nm, RR ∼ 10 Hz, PW ∼ 10 ns, Phocus, Opotek, California) was guided through a custom-made silica fused-end fiber bundle (CeramOptics GmbH, Bonn, Germany) consisting of 480 fibers. The illumination spot at a distance of 3 cm from the surface of the detection array has ∼1 cm diameter. PA signals are acquired with sampling frequency of 40 MS∕s using a custom-made DAQ system consisting of 16 multichannel analog-to-digital converters (FalkensteinMikrosysteme, Taufkirchen, Germany), which were triggered by the Q-switch output of the laser. Using a graphic processing unit (GPU), the system allows imaging at a frame rate up to 50 frames per second. The volumetric imaging rate is limited by pulse RR of the laser and processing speed of the image reconstruction method. The system was demonstrated for several applications, and the recent ones are discussed below.
In vivo imaging of the carotid arteries in humans
The ability to image hemoglobin makes the PAT a potential tool for imaging vascular diseases. Using the system, imaging of the carotid arteries (cca) in healthy human volunteers was demonstrated.
105 Figure 6 (b) depicts a device that is similar in operation to medical US imaging. 77 Figures 6(c) and 6(d) show the real-time two-dimensional (2-D) multispectral optical tomography (MSOT) images of oxyhemoglobin (OHb) in human hallux. The MSOT imaging was done at a video-rate of 50 frames per second, with the ability to select a different wavelength for each frame. Such a high frame rate was enabled by a fast-tuning OPO and GPU.
In vivo imaging of tissue chromophores on human forearm
The system design is shown in Fig. 7(a) ; here high RR OPO laser (PW ∼ 5 ns, PE ∼ 20 mJ, RR ∼ 50 Hz) from Innolas Laser GmbH, Germany, was used. 106 The spectral dependence of the optical absorption of the three main tissue chromophores (melanin, Hb, and HbO 2 ) is shown in Fig. 7(b) . The 2-D volumetric PA images collected at different wavelengths and at different time points are shown in Fig. 7(c) .
In vivo imaging of human breast
The system design and representative volumetric frames of breast are shown in Figs. 8(a)-8(c) . 99 The breast is illuminated using the fast tuning OPO laser and volumetric data were acquired at multiple wavelengths in order to recover functional blood oxygenation parameters of the breast vasculature in real time. Here, concentration of the different tissue chromophores, as resolved by the spectral unmixing procedure, is pseudocolored with red, blue, and yellow for HbO 2 , HbR, and melanin, respectively. The yellow spots correspond to melanin-rich skin pigmentations in the skin. Since it only takes 30 ms to acquire multispectral data at three different wavelengths, this approach is equally capable of rendering functional blood oxygenation and total hemoglobin profiles in real time. This is an especially important aspect as elevated levels of hemoglobin and hypoxic behavior were found to strongly correlate with tumor angiogenesis and breast malignancies.
In vivo imaging of lymph node micrometastases and in-transit metastases from melanoma
Recently, the MSOT system was demonstrated for detection of melanoma lymph node micrometastases and in-transit metastases undetectable with fluorine 18 fluorodeoxyglucose (FDG) PET/computed tomography (CT). 107 The MSOT could differentiate even small melanoma metastasis from the other lymphadenopathies in vivo. The study was performed on a mouse B16F10 melanoma limb lymph node metastasis model.
Ring-Array-Based Wearable PAT System
PAT allows in vivo brain imaging at micrometer spatial and millisecond temporal resolution. A 3-D wearable PAT system with ∼200 μm spatial and 170 ms temporal resolutions is demonstrated for brain imaging in a rat while it is walking. 192 signal amplifying channels that were three-to-one multiplexed into 64 DAQ channels. Therefore, three laser pulses are required to collect the data from all the channels. With the rotatable design of the LLG interface, the animal can walk around during imaging, as shown in Fig. 9(c) .
The functional imaging capability of 3-D-wPAT was demonstrated by mapping the cerebral oxygen saturation via multiwavelength irradiation in walking hyperoxic rats as shown in Figs. 9(d) and 9(e) . The animal was placed in an experimental chamber and pure oxygen was pumped into the chamber 100 s after the start of imaging. The imaging duration was 300 s, and a total of 100 images were acquired. Figures 9(d) and 9 (e) present the total cerebral hemoglobin images and sO 2 maps for each acoustic detection layer, respectively. The sO 2 ratio increased throughout the brain vasculature after being supplied with oxygen. As shown in Fig. 9(e) , the regions marked with white arrows underwent increase in oxygen saturation. The obtained results are consistent with the idea that hemodynamic changes initiate in medial and ventral brain regions, reinforcing the importance and significance of deep-penetration 3-D brain imaging.
All the PAT systems discussed in Sec. 3 are based on homemade/custom-made array US transducers. The challenge in building array based transducers is that they require parallel data acqusition (DAQ) systems, which are expensive and most of them are also custom-made. Such systems are also not approved by the Food and Drug Administration (FDA) in the United States at present, and hence they are not preferred in clinical use. Also these systems are not optimized to perform standard US imaging. On the other hand, clinical US imaging systems are FDAapproved devices and they are routinely used in clinics/hospitals by the clinicians. Moreover, PAI and pulse-echo US imaging share the same US-receiving mechanism. Hence, PAT integrated with a clinical US system will be more acceptable to the clinicians as they will be able to provide dual-modal imaging. They can provide traditional US imaging, Doppler blood flow imaging, and so on on top of PAI. In the following section, we will discuss the integrated clinical US systems with PAT.
Clinical Ultrasound Imaging Systems
Integrated with PAT
Performing Sentinel Lymph Node Biopsy for Breast Cancer Patients
In staging of cancer, including breast and melanoma cancers, SLN biopsy (SLNB) is a standard procedure. 109, 110 A positive biopsy result suggests that cancer has spread to the node and probably to distant organs. The identification rate and sensitivity of SLNB technique are less than 95%, even in experienced hands. [109] [110] [111] Moreover, the complications associated with the SLNB procedure include seroma formation, lymphedema, sensory nerve injury, and limitation in the range of motion. 112, 113 Several studies have been conducted proposing noninvasive identification of SLN using a dual-modal PAT-US platform in a small animal model. [114] [115] [116] Recently, a handheld PAT-US system [ Fig. 10(a) ] was used to identify the SLN in breast cancer patients. 117 The system was developed by modifying a clinical US system (iU22, Philips Healthcare). The excitation source was a tunable dye laser (PW ∼ 6.5 ns, RR ∼ 10 Hz, PrecisionScan-P, Kaarst, Germany) pumped by a 532-nm Nd:YAG laser (QuantaRay PRO-350-10, Spectra-Physics, Santa Clara, California). Light was delivered to the sample by a fused-end, bifurcated fiber bundle. To improve the PA detection sensitivity and handiness, the fiber bundles and UST array (L12-5 and L8-4, Philips) were integrated into a single probe as shown in Fig. 10(a) . The light fluence on the skin was ∼10 mJ∕cm 2 (less than 20 mJ∕cm 2 ANSI safety limit). The signals were acquired by a custom-built DAQ card. The DAQ system was synchronized with laser triggering by an FPGAbased card that also performs PAT reconstruction based upon a delay-and-sum beamforming algorithm. The system can provide a frame rate of 5 Hz for PA, US, and coregistered imaging.
For SLNB, the PAT-US system can serve as a real-time modality to first locate the SLN and then guide a fine or core needle for lymph node sampling. 115, 118 Figure 10(b) shows the coregistered PA-US image, revealing the SLN and the needle used to insert the titanium marking clip. The contrast from the needle in the PAT image is much higher than that in the corresponding US image because the US array receives more emitted PA energy than it does reflected ultrasonic energy. The system is capable of locating lymph nodes via anatomical features in US and to verify the lymph node as sentinel using PAT. In addition, these results illustrate the feasibility of PAT-US to guide needles to the SLN in breast cancer patients. SLN identification can be improved further using multiwavelengths to spectrally resolve methylene blue (MB, a routinely used contrast agent in clinical practice) from blood in nearby vessels. MB absorption is strongest at 665 nm, while its absorption is very weak at wavelengths longer than 750 nm. Figure 10 One of the challenges of integrating the PAT with a clinical US system is to obtain the raw channel radio-frequency (RF) data before beamforming is done. Once these RF data are obtained, PA reconstruction is done and displayed on the monitor. The Philips iU22 clinical US system after integrating with PAT is capable of providing the raw channel RF data before beamforming. However, this feature is not available on the commercially available iU22 US system in the market. Therefore, the researchers will have to collaborate with the Philips research team to use their system specifically modified for that purpose. This limits the accessibility of such a system to many researchers interested in doing integrated US and PA imaging. Recently, there are many other US companies coming up with research US platforms capable of extracting raw channel RF data and these systems are made available for researchers to purchase off the shelves. Below we will discuss such systems and their recent progress.
High-Frame Rate (7000 Hz) Photoacoustic Imaging
Using a handheld PLD-PAT/US probe, a real-time phantom imaging up to 15 mm depth was done at 20 fps. 119 With the OPO-PAT/US system, in vivo real time imaging of blood vessels in a rat was performed at 20 fps. 120 Recently, a high-frame rate (7000 Hz) PA imaging system was demonstrated by integrating a high RR PLD (the PLD used here is same as the one used in Sec. South Korea). 121 The PLD output was made narrower using a cylindrical lens to illuminate 15 mm × 5 mm area with 1.87 mJ∕cm 2 energy density. The PA signals generated were acquired by a linear array transducer (LAT) (L3-12 transducer, Alpinion, South Korea) consisting of 128 array elements. The probe has f c ∼ 8.5 MHz (95% BW), array element pitch 0.3 mm, and elevation height 4.5 mm. The Ecube system has a 40-MHz sampling frequency and 12-bit ADC to acquire the data and a data transfer speed of 6 Gb∕s. The clinical US system captures and displays the PAI images in real-time.
The L3-12 linear array UST can be operated in two different modes, mode-1: using all the 128 arrays elements and mode-2: using 64 channels elements only (element numbers 1-64 or 65-128). PA imaging was done for the different flowrates. Using mode-1 and mode-2, 3500 fps and 7000 fps PA images were recorded. Figures 11(a)-11(h) show the PA images of ink A high frame rate of 7000 fps photoacoustic B-scan imaging was feasible with the PLD and Ecube clinical US system, whereas with the 10-Hz Nd:YAG/OPO laser only 10 fps (max) PA imaging was possible. With 7000-fps frame rate, the theoretical flow rate that can be measured is up to 134.4 m∕s. However, future studies need to be conducted to explore the various in vivo applications where high frame rate PA imaging would be beneficial, such as imaging circulating tumor cells, heart valves, and blood vessel.
Slit-Enabled UST Array for High Elevational Resolution PAT Imaging
A dual-modality PA-US system is increasingly used in preclinical/clinical imaging. However, the 3-D imaging capability of a linear array is limited due to its poor elevational resolution.
To overcome this problem, a metal slit was used at the array focus. 122 The imaging system involved a 128-element UST array (f c ¼ 5 MHz, elevation focus ∼25 mm, ATL/Philips L7-4) and an Nd:YAG laser (λ ∼ 532 nm, PW ∼ 10 ns, RR ¼ 10 Hz, PE ¼ 18 mJ∕pulse, Surelite SL III-10, Continuum). PA signals received by the L7-4 array were multiplexed and digitalized by a 64-channel DAQ (Vantage, Verasonics, Redmond, Washington). A thin slit [ Fig. 12(a) ] was formed by two metal blades with 500 μm thickness. The bottom blade was fixed in position while the top blade was mounted on a translation stage, which allowed easy and precise control of the slit opening. To prevent sound signal transmission directly through the plate, they glued 5-mm foam on the back surface of the blade (facing the transducer) as an acoustic absorber. The slit causes the incoming PA waves to diffract along the elevation direction and, hence, significantly improves the elevation detection aperture and resolution. Figures 12(b)-12(d) show the in situ PAT results on a mouse abdomen without and with slit-enabled PAT. The slit improves the elevation resolution by 10 times without compromising scanning time.
Photoacoustic Imaging Using Two Linear Array Transducers
ATs are widely used in clinical US systems, but their application in PAT is still limited due to the limited-angle of view that affects the image quality. Using two LATs, one can acquire a PAT signal from different orientations. The positions of the two transducers can be adjusted to fit the specific geometry of an imaging site. Figure 13(a) shows the schematic of the experimental setup for PAT imaging with two transducers. The laser source contains a Q-switched 532-nm Nd:YAG/OPO laser (RR ¼ 10 Hz, PW ∼ 5 ns, tunable λ ¼ 680 to 2550 nm, Surelite OPO Plus, Continuum). The system used two identical commercial LATs controlled by a SonixMDP US system (Ultrasonix Medical Corporation, Richmond). The US imaging system was capable of enabling selected transducer channels for acoustic wave transmitting. The two LATs (L14-5/38 Linear) were positioned in the same plane. Each one has 128 channels with 7.2-MHz center frequency, minimum 70% fractional BW (at −6 dB), and 0.3-mm element pitch. The acoustic signal received by the transducer array was sent to a specialized research module, SonixDAQ for DAQ. This module acquires and digitizes prebeamformed radio-frequency signal from all the 128 channels individually at a sampling rate of 40 MHz and 12-bit resolution. Both PA and US images were reconstructed using delay-andsum beamforming algorithm. The lateral and axial resolutions of the systems are 0.52 and 0.44 mm, respectively. The system was tested on phantoms and a human hand. A leaf skeleton embedded in bovine gelatin, mimicking blood vessel branches in tissue, was imaged. A photograph of the sample and the transducer positions are shown in Fig. 13(b) . The relative angle between the two LATs was ∼90 deg. In both images [Figs. 13(c) and 13(d)], each linear transducer can only capture part of the leaf skeleton structure which was near parallel to the lateral axis of the transducer. By incorporating the acoustic signals acquired by both linear transducers, a more complete leaf skeleton structure was obtained, as indicated in Fig. 13(e) . The system was demonstrated for in vivo imaging of the human hand and the results promise that the two transducer approach has potential to be implemented in clinical applications.
Full-View Photoacoustic Imaging Using Thermal Encoding
PAI of irregular objects may miss important features because PA waves propagate normal to structure boundaries and may miss the UST if it has a limited angle of view. To overcome such problems, an ultrasonic heating encoded approach was demonstrated. 124 The experimental setup is illustrated in Fig. 14(a) . The output of excitation 532-nm Nd:YAG laser (PW ¼ 10 ns, RR ¼ 20 Hz, Quantel, France) was expanded by a concave lens to illuminate the sample. A linear UST array with 256 elements (f c ∼ 15 MHz, BW ∼ 9 MHz, MS200, VisualSonics Inc., Canada) was used to detect the PA waves. The probe was connected to an US imaging system (Vevo LAZR, VisualSonics Inc., Canada), which could generate a 2-D PA image using four laser pulses. The system can provide 257 and 113 μm lateral and axial resolutions, respectively.
A custom-made ultrasonic heating transducer (f c ¼ 7.5 MHz, focal diameter 178 μm, focal depth 445 μm) can generate a focal spot size smaller than the lateral resolution of the linear transducer array for isotropic detection. A function generator synthesized a 7.5-MHz sinusoidal signal, whose amplitude was modulated by another sinusoidal wave at a frequency of 0.5 Hz. The 7.5-MHz sinusoidal signal modulated by 0.5-Hz signal was amplified to drive the heating UST. To avoid interference between the acoustic heating and PA detection, the heating US was turned off for 1 ms before and after each PA acquisition. At each heating spot, 50 consecutive 2-D PA images were acquired at a speed of 5 images∕s and reconstructed using the filtered backprojection algorithm. As a proof of concept, full-view in vivo mouse vascular imaging was performed with and without thermal encoding as shown in Fig. 14(b) . Only horizontal blood vessel segments [features in green in Fig. 14(b) ] are visible in the original PA [green signal in Fig. 14(b) ] mode and more blood vessels are visible with thermal encoding [red signal in Fig. 14(b) ] due to the enlarged angle of view. Since ultrasonic heating can be focused deeply, this technique can be applied to deep-tissue imaging and is promising for full-view imaging of other features of biomedical interest, such as tumor margins.
Human Finger Joint Photoacoustic Imaging
A noninvasive 2-D PAT system based on single-element UST 125 and multiple single-element USTs 126 were reported for imaging of human peripheral joints toward diagnosis of inflammatory arthritis. Later, a 3-D quantitative PAT (3-DqPAT) system was 128 The cross-sectional PA images of a healthy joint clearly showed major internal structures including phalanx and tendons. The in vivo PAI results obtained were compared with 3.0T MRI images of the finger joint. A PA/US dual-modality system was reported for imaging human peripheral joints. 129 The system utilizes a commercial US unit (Z.ONE, ZONARE Inc.) for both US and PA imaging. A linear array (L10-5, ZONARE Inc.), with a working band of 5 to 10 MHz was used to collect signals. The lateral resolution of the PA imaging in the focal plane was ∼300 μm at a distance ∼20 mm from the probe surface. In vivo results on healthy human volunteers revealed that the system could provide both the structural and functional information of intra-and extra-articular tissues.
A handheld US probe smartly integrated with a PLD was reported for dual-modality PA-US imaging [ Fig. 15(a) ]. 119, 130 The US detection was performed with an US array (Esaote SL3323 probe) composed of 128 elements, each with a length of 5 mm and a pitch of 0.245 mm. The array has a central frequency of 7.5 MHz and a measured −6 dB BW of around 100%. The array incorporates an acoustic lens to focus the US in the elevation plane at about 20 mm distance. The probe, connected to an US scanner from MyLab_One, ESAOTE Europe B.V, Maastricht, the Netherlands. A PLD (λ ¼ 805 nm, PW ¼ 130 ns, RR ¼ 10 kHz, PE ¼ 0.56 mJ∕pulse) from Quantel (Paris, France) was integrated inside the US probe. The PLD output suffers from bad beam quality and large divergence angle. Using a fused silica diffuse optical element (efficiency 80%) composed of 400-μm diffractive cells and eight discrete phase levels, the beam is homogenized and reshaped in rectangular form onto the skin. The PLD can provide fluence up to 1.3 mJ∕cm 2 on 18.2 × 2.3 mm 2 skin area. The PA-US system allows, PA imaging at 10 images∕s (after averaging 20 frames per image), and US imaging at 80 frames∕s (no averaging). Figures 15(b) and 15(c) show combined PA-US images of the sagittal and transverse plane of a human proximal interphalangeal (PIP) joint. Skin, bone, and joint gap are clearly visible in the US images (gray). PA images (yellowish red) depict the skin and blood vessels. The deeper PA signals correspond to the reflection of skin PA signal on bone. This bedside device has a potential to visualize rheumatoid arthritis.
All the systems described in this section are comprised of clinical US imaging platform modified to incorporate PAI making it a dual-modal imaging system. Although the PA images obtained from LATs suffer from limited view problems and lower sensitivity (compared with large single-element US transducers), this approach holds promise to make PAI into clinical one day. This is validated by interests from several small and large companies venturing into developing a commercial PAI system. In the next section, we will briefly discuss the efforts made by the companies.
Commercially Available PAT Systems
Worldwide several companies are developing commercial US/PAT imaging systems: FUJIFILM VisualSonics Inc., Toronto, Canada; iThera Medical GmbH, Munich, Germany; TomoWave Laboratories Inc, Houston; Seno Medical Instruments Inc., Texas; Endra Inc, Ann Arbor, Michigan; Optosonics Inc., Oriental, North Carolina, and so on. Realtime assessment of tissue hypoxia in vivo was demonstrated using Vevo2100 ultrahigh frequency (f c ∼ 75 MHz, imaging resolution ∼30 μm) US and PAI system from VisualSonics. 131 Recently, in vivo liver iron quantitation 132 and detection of lymph node micrometastases and in-transit metastases from melanoma in a mouse model 107 were demonstrated using iThera inVision-128 and inVision 256-TF, respectively. LOIS-3-D from TomoWave was used for demonstrating melanin nanoparticles as a PA contrast agent. 133 A tomographic PA scanner (Nexus 128, Endra Inc.) was used for animal imaging and contrast agent studies. 134 A dedicated 3-D PAT system from Optosonics was demonstrated for a breast cancer imaging system. 135 Among the large radiology companies, Philips Healthcare has put significant effort to integrate PA imaging with its iU22 US system. 136 Moreover, General Electric has also shown interest in the past on integrating PAI in its US imaging platform. 137 Hopefully, in the future we will see more progress in this domain from these companies as well as other large healthcare companies.
Advancement in PAT Reconstruction Algorithms
The development of the PAT imaging system will be incomplete without the appropriate reconstruction algorithm development in parallel. PAT reconstruction can be considered as an inverse problem. From the boundary PA data, various reconstruction algorithms can be used for obtaining the initial pressure rise distribution inside the tissue. [138] [139] [140] [141] [142] [143] [144] [145] Several advancements have happened in the last couple of years in the PAT reconstruction algorithms: (a) a least-square-based algorithm for accurate reconstruction with a fewer number of transducers, 146 (b) basis pursuit deconvolution algorithm to retain the structural information accurately, 147 (c) filtered-backprojection algorithm, 148 (d) single-stage algorithm for high quality (compared to traditional two-stage algorithms) PA imaging, 149 (e) pulse decomposition algorithm in the time-domain for weak, noisy PA signal reconstruction, 150 (f) an algorithm integrating focal-line-based 3-D image reconstruction with coherent weight to improve the elevation resolution of commercial linear UST array-based PAT, 151 (g) a multiview Hilbert transformation method for full-view PAT imaging using linear UST array, 63 (h) asymmetric DAQ optimized with compressed sensing method for full-view PAT, 152 and (i) improving tangential resolution in PAT with a modified delay-and-sum algorithm.
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Conclusions and Future Directions
In this review, we discussed the state-of-art PAT systems and their applications from laboratory research to clinical patient care. PAT has shown progress in many aspects: from preclinical to clinical, from bench to bedside, from static to dynamic, from 2-D to five-dimensional (5-D) volumetric imaging, from expensive to affordable. However, future undertakings are necessary to further mature the PAT technology for real-time clinical applications.
From the laser excitation point of view, the ultrafast laser technology has advanced from bulk Nd:YAG lasers to tiny LEDs. However, PLDs and LEDs demonstrated so far have low PE (less than 1.5 mJ∕pulse) and high energy tunable PLDs, and LEDs are yet to be developed for deep-tissue and PA spectroscopic imaging. Along with laser technology, the US detection technology is also advancing to produce high frequency and broadband USTs. A Fabry-Perot polymer film etalon can sense US from DC to several tens of MHz. 19, 153 However, it is a contact approach and allows imaging only superficial features located within a few millimeteres inside the tissue surface. The PZT-based USTs have been widely used for US detection. Single-element USTs from 1 MHz to ∼1.2 GHz have been used for PAI. 31, 154 One-dimensional array-based USTs are available up to ∼45 MHz, 2-D array based are up to 70 MHz. 155 Newer technologies for US transducers also have been explored. Capacitive micrimachined ultrasonic trandcuers (CMUTs) have been demonstrated for PAI as well. The ease of making 2-D or 3-D arrays of transducer with this technology, and other advantages like larger bandwidth, easier integration of the CMUTs with other electronics etc. may make this technology suitable for PAI as well. 155, 156 Further investigations are needed to mature this technology to be used both in traditional US imaging as well as in PAI.
From the image reconstruction point of view, recovering the initial pressure distribution alone is also a challenging problem for quantitative PA imaging. In general, a PA signal is a function of optical absorption coefficient and local fluence. To make the PAT a robust quantitative measurement tool, the local fluence must be compensated accurately. A quantitative PAT by stochastic search for direct recovery of the optical absorption field was reported recently. 157 The progress toward this study was summarized in the literature. 158 Extracting the absolute chromophore concentrations from PA images obtained at multiple wavelengths is a nontrivial aspect of PAT but is essential for accurate functional and molecular imaging. More information on the quantitative PAI and its challenges can be found in the review. 159, 160 One of the key application areas of PAT is breast cancer imaging. However, penetration depth is a key obstacle. A penetration depth of ∼4 cm has been achieved in vivo in the human breast using an excitation wavelength of 800 nm. 100 Twente PA mammoscope 161, 162 and volumetric handheld optoacoustic angiography 99 seem to be promising tools for breast cancer studies. However, extensive clinical studies need to be performed on this. A high-pulse-energy wavelength-cycling NIR laser system was designed and developed for 3-D PAT of the breast. 90 It could provide 5-cm deep breast imaging. The laser was designed to improve efficacy and ease of use in the clinic. Wavelengthcycling provides a pulse sequence that repeatedly alternates between two wavelengths (756 and 797 nm) that provide differential imaging. This improves coregistration of captured differential images and quantification of blood oxygen saturation. Extending the penetration depth and image contrast can be achieved by using an exogenous contrast agent with strong absorption in the NIR region. Several contrast agents based on metallic, inorganic, organic nanoparticles, quantum dots, and so on were demonstrated for deep PAT imaging. 22, 163, [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] Research work is progressing to find a stable, nontoxic, biocompatible, and yet powerful exogenous contrast agent for PAT. 163, 174, 175 Very recently, a 12-cm deep-tissue imaging was demonstrated using phosphorus phthalocyanine as an exogenous contrast agent at 1064 nm. 9 Another application of PAT is metabolic rate of oxygen (MRO 2 ) imaging. MRO 2 quantifies metabolism and thus it is crucial for screening and treatment of metabolic diseases, particularly cancers and cerebral disorders. 71 Fortunately, PAT allows complete assessment of MRO 2 on a single imaging modality. The PAT measurement of MRO 2 in humans is expected to have a profound impact on studies of tumor metabolism and neovascularization. Another important aspect in which PAT has shown progressing is multimodal PAT imaging. PAT has been successfully integrated with other complementary imaging techniques, e.g., fluorescence and optical coherent tomography. One may refer to reviews focused on this topic. 71, 72, 176 Overall, PAT has very promising preclinical and clinical applications. Several research groups and companies are also working toward making PAI small, compact, easy-to-use, and low-cost, and, therefore, making it possible for translating into the clinic. Improvement in terms of image quality, penetration depth, imaging speed, cost, and size of the system will further enhance the commercialization and clinical applications of this promising technology.
